From professional translators, enterprises, web pages and freely available translation repositories.
krabbameinslyfjum.
concentrations.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
notkun með krabbameinslyfjum
use with chemotherapy
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
notkun ásamt krabbameinslyfjum
use with chemotherapy
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ekki nota kadcyla ásamt krabbameinslyfjum
do not administer kadcyla in combination with chemotherapy
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ef þú færð mabthera ásamt krabbameinslyfjum
if you are having mabthera with chemotherapy
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
náið eftirlit með þoli á þessum krabbameinslyfjum.
careful monitoring of the tolerance of these anticancer agents.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vectibix ásamt bevacizumabi og öðrum krabbameinslyfjum
vectibix in combination with bevacizumab and chemotherapy regimens
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ekki má nota lynparza samhliða öðrum krabbameinslyfjum.
do not take lynparza if you are taking any other anticancer medicines.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
klínísk verkun í samhliða meðferð með krabbameinslyfjum
clinical efficacy in combination with chemotherapy
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
abraxane á ekki að nota samhliða öðrum krabbameinslyfjum.
abraxane should not be used in combination with other anticancer agents.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
mabthera 1.600 mg er gefið ásamt krabbameinslyfjum.
you will be given mabthera 1600 mg with other medicines called “chemotherapy”.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
mælt er með nánu eftirliti með þoli gagnvart þessum krabbameinslyfjum.
careful monitoring of the tolerance to these anti-cancer agents is recommended.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hins vegar ber einnig að íhuga meðferð með öðrum krabbameinslyfjum.
however, treatment with other chemotherapeutic agents should also be taken into consideration.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
mabthera 1.400 mg má nota eitt sér eða ásamt öðrum krabbameinslyfjum.
mabthera 1400 mg can be given alone or with other medicines called “chemotherapy”.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Í samsettri meðferð með krabbameinslyfjum sem byggir á irinotecani eða oxaliplatini:
in combination with irinotecan- or oxaliplatin-based chemotherapy:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hjá þeim sjúklingum er erbitux notað eitt og sér eða samhliða öðrum krabbameinslyfjum.
in these patients, erbitux is used alone or in combination with other anticancer medicines.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
blóðleysi hefur mjög oft verið tilkynnt þegar mifamurtid er notað með krabbameinslyfjum.
anaemia has very commonly been reported when mifamurtide is used in conjunction with chemotherapeutic agents.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
docetaxel winthrop gefið ásamt platínusamböndum sjúklingum sem hafa ekki áður fengið meðferð með krabbameinslyfjum
docetaxel winthrop in combination with platinum agents in chemotherapy-naïve patients
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
aukaverkanir af notkun depocyte geta verið alvarlegri ef það er gefið samhliða öðrum krabbameinslyfjum.
the severity of adverse events of depocyte may be increased when depocyte is given in combination with other chemotherapeutic agents.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
alvarleiki aukaverkana af völdum dócetaxels getur aukist þegar það er gefið ásamt öðrum krabbameinslyfjum.
the severity of adverse events of docetaxel may be increased when docetaxel is given in combination with other chemotherapeutic agents.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: